The role of Corticotropin-Releasing Factor (CRF) in preclinical models of depression
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Shin, K.H. | - |
dc.date.accessioned | 2021-09-08T09:22:31Z | - |
dc.date.available | 2021-09-08T09:22:31Z | - |
dc.date.issued | 2010 | - |
dc.identifier.issn | 1738-1088 | - |
dc.identifier.issn | 2093-4327 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/118332 | - |
dc.description.abstract | Corticotropin-releasing factor (CRF) has been implicated in the pathophysiology of depression and anxiety, as it plays a critical role in the neuroendocrine, autonomic, and behavioral responses to stress. Moreover, CRF in the extrahypothalamic area has been closely linked to depression and anxiety. As recent studies have strengthened the view that CRF in the dorsal raphe nucleus and locus ceruleus is involved in preclinical animal models of depression, the recent progress concerning CRF is worthy of review. First, we describe the distribution and function of CRF in brain. Then, we present the role of CRF in preclinical animal models of depression. Further research on CRF and its receptors should help to clarify the pathophysiology of depression and improve the treatment of this debilitating disease. Copyright © 2010, Korean College of Neuropsychopharmacology. | - |
dc.format.extent | 11 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.title | The role of Corticotropin-Releasing Factor (CRF) in preclinical models of depression | - |
dc.type | Article | - |
dc.publisher.location | 대한민국 | - |
dc.identifier.scopusid | 2-s2.0-77956633605 | - |
dc.identifier.bibliographicCitation | Clinical Psychopharmacology and Neuroscience, v.8, no.2, pp 63 - 73 | - |
dc.citation.title | Clinical Psychopharmacology and Neuroscience | - |
dc.citation.volume | 8 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 63 | - |
dc.citation.endPage | 73 | - |
dc.type.docType | Review | - |
dc.identifier.kciid | ART001469292 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kciCandi | - |
dc.subject.keywordPlus | protein localization | - |
dc.subject.keywordPlus | review | - |
dc.subject.keywordPlus | anxiety disorder | - |
dc.subject.keywordPlus | autonomic nervous system | - |
dc.subject.keywordPlus | aversive behavior | - |
dc.subject.keywordPlus | behavior | - |
dc.subject.keywordPlus | brain region | - |
dc.subject.keywordPlus | child neglect | - |
dc.subject.keywordPlus | child sexual abuse | - |
dc.subject.keywordPlus | chronic stress | - |
dc.subject.keywordPlus | depression | - |
dc.subject.keywordPlus | dorsal raphe nucleus | - |
dc.subject.keywordPlus | early life stress | - |
dc.subject.keywordPlus | exploratory behavior | - |
dc.subject.keywordPlus | forced swimming test | - |
dc.subject.keywordPlus | grooming | - |
dc.subject.keywordPlus | human | - |
dc.subject.keywordPlus | learned helplessness | - |
dc.subject.keywordPlus | locomotion | - |
dc.subject.keywordPlus | locus ceruleus | - |
dc.subject.keywordPlus | major depression | - |
dc.subject.keywordPlus | neuroendocrine system | - |
dc.subject.keywordPlus | nonhuman | - |
dc.subject.keywordPlus | pathophysiology | - |
dc.subject.keywordPlus | protein function | - |
dc.subject.keywordPlus | serotoninergic nerve cell | - |
dc.subject.keywordPlus | sexual behavior | - |
dc.subject.keywordPlus | social interaction | - |
dc.subject.keywordPlus | solitary tract nucleus | - |
dc.subject.keywordPlus | stress | - |
dc.subject.keywordPlus | vagus nerve dorsal nucleus | - |
dc.subject.keywordPlus | 3 (6 dimethylamino 4 methyl 3 pyridinyl) 7 dipropylamino 2,5 dimethylpyrazolo[1,5 a]pyrimidine | - |
dc.subject.keywordPlus | amitriptyline | - |
dc.subject.keywordPlus | antidepressant agent | - |
dc.subject.keywordPlus | benzodiazepine derivative | - |
dc.subject.keywordPlus | citalopram | - |
dc.subject.keywordPlus | corticotropin releasing factor | - |
dc.subject.keywordPlus | corticotropin releasing factor antagonist | - |
dc.subject.keywordPlus | corticotropin releasing factor receptor 1 | - |
dc.subject.keywordPlus | corticotropin releasing factor receptor 2 | - |
dc.subject.keywordPlus | fluoxetine | - |
dc.subject.keywordPlus | noradrenalin | - |
dc.subject.keywordPlus | r 278995 | - |
dc.subject.keywordPlus | serotonin | - |
dc.subject.keywordPlus | serotonin uptake inhibitor | - |
dc.subject.keywordPlus | unclassified drug | - |
dc.subject.keywordPlus | anxiety | - |
dc.subject.keywordAuthor | Anxiety | - |
dc.subject.keywordAuthor | Bed nucleus of the stria terminalis | - |
dc.subject.keywordAuthor | Central nucleus of the amygdala | - |
dc.subject.keywordAuthor | Corticotropin releasing factor | - |
dc.subject.keywordAuthor | Corticotropin releasing factor receptor | - |
dc.subject.keywordAuthor | Depression | - |
dc.subject.keywordAuthor | Dorsal raphe nucleus | - |
dc.subject.keywordAuthor | Locus ceruleus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
145 Anam-ro, Seongbuk-gu, Seoul, 02841, Korea+82-2-3290-2963
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.